Cargando…

Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan

BACKGROUND: Kabul has over 12,000 people who inject drugs (PWID), most of them heroin users, and opioid substitution therapy has recently been introduced as an effective method to reduce opioid use. We aimed to evaluate a pilot Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, Afghanistan,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiseñor-Escudero, Horacio, Vu, Alexander, Wirtz, Andrea L, Familiar-Lopez, Itziar, Berry, Mark, Mfochive, Iliassou, Engineer, Cyrus, Farhad, Ahmad, Tschakarjan, Senop, Wisse, Ernst, Paikan, Feda M, Burnham, Gilbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559065/
https://www.ncbi.nlm.nih.gov/pubmed/26337832
http://dx.doi.org/10.1186/s12954-015-0062-1
_version_ 1782388716028821504
author Ruiseñor-Escudero, Horacio
Vu, Alexander
Wirtz, Andrea L
Familiar-Lopez, Itziar
Berry, Mark
Mfochive, Iliassou
Engineer, Cyrus
Farhad, Ahmad
Tschakarjan, Senop
Wisse, Ernst
Paikan, Feda M
Burnham, Gilbert
author_facet Ruiseñor-Escudero, Horacio
Vu, Alexander
Wirtz, Andrea L
Familiar-Lopez, Itziar
Berry, Mark
Mfochive, Iliassou
Engineer, Cyrus
Farhad, Ahmad
Tschakarjan, Senop
Wisse, Ernst
Paikan, Feda M
Burnham, Gilbert
author_sort Ruiseñor-Escudero, Horacio
collection PubMed
description BACKGROUND: Kabul has over 12,000 people who inject drugs (PWID), most of them heroin users, and opioid substitution therapy has recently been introduced as an effective method to reduce opioid use. We aimed to evaluate a pilot Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, Afghanistan, particularly to (1) describe characteristics of the participants enrolled in the program and (2) identify factors associated with client retention in the OSTPP. FINDINGS: Two cross-sectional surveys evaluated participants attending the OSTPP at baseline (n = 83) and 18 months after (n = 57). Questionnaires assessed socio-demographic, drug use behavior, and general and mental health factors. After 18 months, 57 participants remained in the OSTPP. Participants lost to follow-up were younger (p < 0.01) and married (p < 0.01) and had no family contact (p < 0.01). Participants at 18 months reported no criminal activity in the last month and only two (3.5 %) reported heroin use in the last month, constituting significant decreases from baseline. CONCLUSIONS: While preliminary results are promising, further evaluation is needed to determine the feasibility of implementing OSTPP in this setting and effectiveness in reducing injection risk behaviors in Afghanistan.
format Online
Article
Text
id pubmed-4559065
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45590652015-09-04 Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan Ruiseñor-Escudero, Horacio Vu, Alexander Wirtz, Andrea L Familiar-Lopez, Itziar Berry, Mark Mfochive, Iliassou Engineer, Cyrus Farhad, Ahmad Tschakarjan, Senop Wisse, Ernst Paikan, Feda M Burnham, Gilbert Harm Reduct J Brief Report BACKGROUND: Kabul has over 12,000 people who inject drugs (PWID), most of them heroin users, and opioid substitution therapy has recently been introduced as an effective method to reduce opioid use. We aimed to evaluate a pilot Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, Afghanistan, particularly to (1) describe characteristics of the participants enrolled in the program and (2) identify factors associated with client retention in the OSTPP. FINDINGS: Two cross-sectional surveys evaluated participants attending the OSTPP at baseline (n = 83) and 18 months after (n = 57). Questionnaires assessed socio-demographic, drug use behavior, and general and mental health factors. After 18 months, 57 participants remained in the OSTPP. Participants lost to follow-up were younger (p < 0.01) and married (p < 0.01) and had no family contact (p < 0.01). Participants at 18 months reported no criminal activity in the last month and only two (3.5 %) reported heroin use in the last month, constituting significant decreases from baseline. CONCLUSIONS: While preliminary results are promising, further evaluation is needed to determine the feasibility of implementing OSTPP in this setting and effectiveness in reducing injection risk behaviors in Afghanistan. BioMed Central 2015-09-04 /pmc/articles/PMC4559065/ /pubmed/26337832 http://dx.doi.org/10.1186/s12954-015-0062-1 Text en © Ruiseñor-Escudero et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Brief Report
Ruiseñor-Escudero, Horacio
Vu, Alexander
Wirtz, Andrea L
Familiar-Lopez, Itziar
Berry, Mark
Mfochive, Iliassou
Engineer, Cyrus
Farhad, Ahmad
Tschakarjan, Senop
Wisse, Ernst
Paikan, Feda M
Burnham, Gilbert
Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title_full Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title_fullStr Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title_full_unstemmed Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title_short Cross-sectional assessments of participants’ characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan
title_sort cross-sectional assessments of participants’ characteristics and loss to follow-up in the first opioid substitution therapy pilot program in kabul, afghanistan
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559065/
https://www.ncbi.nlm.nih.gov/pubmed/26337832
http://dx.doi.org/10.1186/s12954-015-0062-1
work_keys_str_mv AT ruisenorescuderohoracio crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT vualexander crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT wirtzandreal crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT familiarlopezitziar crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT berrymark crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT mfochiveiliassou crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT engineercyrus crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT farhadahmad crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT tschakarjansenop crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT wisseernst crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT paikanfedam crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan
AT burnhamgilbert crosssectionalassessmentsofparticipantscharacteristicsandlosstofollowupinthefirstopioidsubstitutiontherapypilotprograminkabulafghanistan